These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34203904)

  • 1. Natural Killer Cell Responses during Human γ-Herpesvirus Infections.
    Münz C
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34203904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell responses to human oncogenic γ-herpesvirus infections.
    Münz C
    Semin Immunol; 2022 Mar; 60():101652. PubMed ID: 36162228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection.
    Caduff N; McHugh D; Rieble L; Forconi CS; Ong'echa JM; Oluoch PO; Raykova A; Murer A; Böni M; Zuppiger L; Schulz TF; Blackbourn DJ; Chijioke O; Moormann AM; Münz C
    Cell Rep; 2021 May; 35(5):109056. PubMed ID: 33951431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory NKG2A
    Vietzen H; Staber PB; Berger SM; Furlano PL; Kühner LM; Lubowitzki S; Pichler A; Strassl R; Cornelissen JJ; Puchhammer-Stöckl E
    Front Immunol; 2023; 14():1183788. PubMed ID: 37426645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.
    Hatton O; Strauss-Albee DM; Zhao NQ; Haggadone MD; Pelpola JS; Krams SM; Martinez OM; Blish CA
    Front Immunol; 2016; 7():607. PubMed ID: 28018364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses.
    Münz C
    Front Cell Infect Microbiol; 2021; 11():605258. PubMed ID: 33842383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
    Williams LR; Quinn LL; Rowe M; Zuo J
    J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.
    Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H
    J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
    Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
    Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection.
    Chijioke O; Landtwing V; Münz C
    Front Immunol; 2016; 7():323. PubMed ID: 27621731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity.
    Elbasani E; Gramolelli S; Günther T; Gabaev I; Grundhoff A; Ojala PM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in NKG2A and NKG2C Subsets of Natural Killer Cells Following Epstein-Barr Virus Reactivation in CTLA4Ig-based Haploidentical Transplantation Is Associated With Increased Chronic Graft-Versus-Host Disease.
    Jaiswal SR; Bhakuni P; Bhagwati G; Aiyar HM; Chakrabarti A; Chakrabarti S
    Transplantation; 2020 Jan; 104(1):e23-e30. PubMed ID: 31478993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
    Katano H
    Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age.
    Müller-Durovic B; Grählert J; Devine OP; Akbar AN; Hess C
    Aging (Albany NY); 2019 Jan; 11(2):724-740. PubMed ID: 30686790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
    King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
    J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
    Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
    J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
    Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
    Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.
    Wei F; Zhu Q; Ding L; Liang Q; Cai Q
    Virol Sin; 2016 Oct; 31(5):395-405. PubMed ID: 27624182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.